Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways (Q44822086)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 March 2004

Language	Label	Description	Also known as
English	Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways	scientific article published on 30 March 2004

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

0 references

apoptotic process

1 reference

based on heuristic

inferred from title

author name string

Suwei Wang

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Eugene A Konorev

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Srigiridhar Kotamraju

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Joy Joseph

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Shasi Kalivendi

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

B Kalyanaraman

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

30 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

279

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

25535-25543

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Early and delayed clinical cardiotoxicity of doxorubicin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Signaling pathways activated by daunorubicin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

The p53 network

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

p53: puzzle and paradigm

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

p53, the cellular gatekeeper for growth and division

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Redox regulation of transcriptional activators

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Cellular oxidative stress and the control of apoptosis by wild-type p53, cytotoxic compounds, and cytokines

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Phorbol esters attenuate the expression of p53 in cells treated with doxorubicin and protect TS-P53/K562 from apoptosis.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

bax-deficiency promotes drug resistance and oncogenic transformation by attenuating p53-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Overexpression of manganese superoxide dismutase promotes survival in cell lines after doxorubicin treatment

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Induction of apoptosis by chemotherapeutic drugs without generation of reactive oxygen species

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Caspases: killer proteases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Mitochondria and apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Reactivity of mono-meso-substituted iron(II) octaethylporphyrin complexes with hydrogen peroxide in the absence of dioxygen. Evidence for nucleophilic attack on the heme

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

GPx-1 gene delivery modulates NFkappaB activation following diverse environmental injuries through a specific subunit of the IKK complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Doxorubicin induces apoptosis and CD95 gene expression in human primary endothelial cells through a p53-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Chemoprotection from p53-dependent apoptosis: potential clinical applications of the p53 inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Benzo[a]pyrene activates the human p53 gene through induction of nuclear factor kappaB activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M400944200

21 January 2018

Identifiers

10.1074/JBC.M400944200

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44822086&oldid=2047875632"